Shelter Pharma

BSE: SHELTER · Pharmaceuticals

52W Range₹23 ₹47

Limited coverage

We are not actively covering this company or have limited coverage today. Click to request coverage.

Snapshot

Unlock Shelter Pharma's vital signs

Growth · Profitability · Valuation · Strength · Conviction

Company Overview

Business

Shelter Pharma Limited is an Ahmedabad-based pharmaceutical company specialising in the manufacturing and marketing of herbal and ayurvedic formulations. The company serves both human healthcare and veterinary segments with a diverse product portfolio including tablets, syrups, ointments, and powders.

Business Model

The company generates revenue by manufacturing and distributing ayurvedic and herbal products for human wellness and animal health. It leverages a manufacturing facility in Himatnagar to supply domestic and select international markets.

Growth Outlook

Growth is driven by the integration of traditional ayurvedic principles with modern manufacturing standards to expand its presence in the herbal medicine sector. The company aims to scale its reach across its human health and veterinary divisions.

Key Risks

  • Regulatory Compliance. The company faces risks related to evolving quality standards and regulatory approvals for ayurvedic and herbal formulations.
  • Market Competition. Intense competition from both established pharmaceutical firms and unorganised players in the herbal medicine space may impact market share.
  • Raw Material Volatility. Fluctuations in the cost and availability of herbal ingredients and raw materials could affect production costs and profit margins.

Start your research today

Unlock AI insights, financials, peers and live data on Shelter Pharma and 5,000+ companies — free.

Start your research

Peers · Pharmaceuticals

CompanyMkt CapP/EEV/EBITDARev Gr YoYEBITDA MgnROEROCE1Y Return
Shelter PharmaSHELTER
₹55 Cr17.4%-27.2%
Albert DavidALBERTDAVD
₹513 Cr22.7313.4811.4%11.0%5.8%7.5%+12.1%
Jenburkt Pharmaceuticals LimitedJENBURPH
₹463 Cr13.318.4632.0%17.6%23.2%-4.3%
Haleos Labs LimitedHALEOSLABS
₹452 Cr28.6012.72-3.1%13.6%7.4%10.3%
TranschemTRANSCHEM
₹424 Cr98.7668.07-100.0%177.7%5.3%7.0%+592.6%
Medicamen BiotecMEDICAMEQ
₹338 Cr33.5915.5324.7%11.3%4.1%6.2%-27.9%

As of Mar 2026

Financials